CD4 and cholangiocarcinoma: Regarding T lymphocyte subsets, both CCA and HCC patients show a decreased percentage of IFNγ+IL-17+ CD4 T cells (Th1/17), IL-17+ CD4 T cells (Th17), and IL-17+ CD8 T cells (Tc17).